Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III, Prospective, Multicentre, Open Label, Extension Study Assessing the Long Term Safety and Efficacy of Repeated Treatment With DYSPORT® Used in the Treatment of Lower Limb Spasticity in Children With Dynamic Equinus Foot Deformity Due to Cerebral Palsy

NCT01251380 is registered in ClinicalTrials.gov with Ipsen as lead sponsor.

NCT NCT01251380
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01251380 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III, Prospective, Multicentre, Open Label, Extension Study Assessing the Long Term Safety and Efficacy of Repeated Treatment With DYSPORT® Used in the Treatment of Lower Limb Spasticity in Children With Dynamic Equinus Foot Deformity Due to Cerebral Palsy
Lead sponsor
Ipsen
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2011
Completion date
January 31, 2015
Enrollment
216 (actual)
Sites
27

Conditions

As the registry lists them; a condition with its own page is linked.

cerebral palsy, children, muscle spasticity